Hos aber, der fik daglige subkutane doser gennem 6 måneder, fandt man øget forekomst af renal tubulær mineralisering ved doser lavere end de kliniske doser.
In monkeys receiving daily subcutaneous doses for 6 months, there was an increased occurrence of renal tubular mineralization at exposure levels below clinical exposure levels.